SCHEMBL2166988

SCHEMBL2166988

CCC(=O)NC(=Cc1ccc(C)c(Cl)c1)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.40
▸ HPGD P15428 4/20 0.40
▸ MAPT P10636 4/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ITGB1 P05556 2/20 0.39
▸ ITGA4 P13612 2/20 0.39
▸ TSHR P16473 2/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ POLB P06746 2/20 0.38
▸ PKM P14618 1/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ AGTR1 P30556 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ LMNA P02545 1/20 0.36
▸ NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3093817 0.86 MCL1 (0.47) ALDH1A1MAPTMAPK1MEN1ALOX15
SCHEMBL3093807 0.86 MCL1 (0.47) ALDH1A1MAPTMAPK1MEN1ALOX15
SCHEMBL3093825 0.86 MCL1 (0.47) ALDH1A1MAPTMAPK1MEN1ALOX15
SCHEMBL1206816 0.82 TSHR (0.38) ALDH1A1MAPTMAPK1MEN1ALOX15
SCHEMBL7974579 0.76 MEN1 (0.44) HPGDMAPTMEN1KMT2AL3MBTL1
SCHEMBL14135332 0.76 AKR1C3 (0.48) ALDH1A1MAPTMEN1KMT2ARECQL
SCHEMBL2165651 0.75 ALDH1A1 (0.35) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL1206159 0.75 RECQL (0.55) ALDH1A1HPGDMAPTMEN1KMT2A
Methyl Alcohol SCHEMBL8740641 0.74 AKR1C3 (0.47) ALDH1A1MAPTMEN1KMT2ARECQL
SCHEMBL2165956 0.74 MCL1 (0.48) ALDH1A1MAPTITGB1ITGA4MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985747-B2 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-26 — — US disclosed
US-20100249114-A1 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-30 — — US disclosed
US-7700598-B2 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-20 — — US disclosed
US-20090176770-A1 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176770-A1 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions CALCRL, CALCR, CALCA ALDH1A1 1335/4885HPGD 387/4885MAPT 972/4885
US-20100249114-A1 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions CALCRL, CALCR, CALCA ALDH1A1 1335/4885HPGD 387/4885MAPT 972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback